In India, from the late 1960s to the early 2000s, a consortium of three premier financial institutions gave projects long-term loans based on tangible assets. The consortium was abandoned in 2001. A transition away from the institutional logics of consortium financing is associated with a rise in the research and development activity of pharmaceutical firms. Changes in financial sector rules impacted Indian firms’ capability transformation. Management research needs to consider institutional logics changes in assessing the influence of financial factors on firms’ capabilities creation.
